Trial Profile
Phase I trial of B-701 in patients with relapsed/refractory t(4;14)-positive multiple myeloma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Vofatamab (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 08 Apr 2015 New trial record